BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20854713)

  • 41. Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period.
    Rizzo C; Rota MC; Bella A; Alfonsi V; Declich S; Caporali MG; Ranghiasci A; Lapini G; Piccirella S; Salmaso S; Montomoli E
    Vaccine; 2010 Apr; 28(20):3558-62. PubMed ID: 20307592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiological investigation of an outbreak of pandemic influenza A (H1N1) 2009 in a boarding school: serological analysis of 1570 cases.
    Li T; Liu Y; Di B; Wang M; Shen J; Zhang Y; Chen X; Yuan J; Wu J; Li K; Lu E; Wu Y; Hao A; Chen X; Wang Y; Liu J; Pickerill S; Zheng B
    J Clin Virol; 2011 Mar; 50(3):235-9. PubMed ID: 21195022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A review of the dynamics and severity of the pandemic A(H1N1) influenza virus on Réunion island, 2009.
    D'Ortenzio E; Renault P; Jaffar-Bandjee MC; Gaüzère BA; Lagrange-Xélot M; Fouillet A; Poubeau P; Winer A; Bourde A; Staikowsky F; Morbidelli P; Rachou E; Thouillot F; Michault A; Filleul L
    Clin Microbiol Infect; 2010 Apr; 16(4):309-16. PubMed ID: 20121825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influenza A(H1N1)2009 antibody seroprevalence in Scotland following the 2010/11 influenza season.
    Adamson WE; McGregor EC; Kavanagh K; McMenamin J; McDonagh S; Molyneaux PJ; Templeton KE; Carman WF
    Euro Surveill; 2011 May; 16(20):19871. PubMed ID: 21616049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and epidemiological features of 2009 pandemic H1N1 influenza differ slightly according to seroprevalence status during the second wave in the general population in México.
    Elizondo-Montemayor L; Hernández-Torre M; Ugalde-Casas PA; Santos-Guzmán J; Serrano-González M; Gutiérrez NG; Lam-Franco L; Tamargo-Barrera D; Martínez U; Bustamante-Careaga H; Alvarez MM; Schultz-Cherry S
    Respir Care; 2012 Oct; 57(10):1586-93. PubMed ID: 22418453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response to a monovalent 2009 influenza A (H1N1) vaccine.
    Greenberg ME; Lai MH; Hartel GF; Wichems CH; Gittleson C; Bennet J; Dawson G; Hu W; Leggio C; Washington D; Basser RL
    N Engl J Med; 2009 Dec; 361(25):2405-13. PubMed ID: 19745216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The seroprevalence of pandemic influenza H1N1 (2009) virus in China.
    Xu C; Bai T; Iuliano AD; Wang M; Yang L; Wen L; Zeng Y; Li X; Chen T; Wang W; Hu Y; Yang L; Li Z; Zou S; Li D; Wang S; Feng Z; Zhang Y; Yu H; Yang W; Wang Y; Widdowson MA; Shu Y
    PLoS One; 2011 Apr; 6(4):e17919. PubMed ID: 21533034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preexisting antibodies against pandemic 2009 influenza A (H1N1) virus in Taiwan.
    Chang SC; Chang CM; Huang YC; Chiu CH; Shih SR; Lin TY
    Clin Infect Dis; 2010 Dec; 51(12):1465-7. PubMed ID: 21082879
    [No Abstract]   [Full Text] [Related]  

  • 50. Pandemic influenza H1N1: reconciling serosurvey data with estimates of the reproduction number.
    Glass K; Kelly H; Mercer GN
    Epidemiology; 2012 Jan; 23(1):86-94. PubMed ID: 22089631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pandemic influenza A/H1N1 2009 antibodies in the metropolitan area of Buenos Aires in Argentina.
    Labato MI; Contrini MM; Lazzarini D; Campos AM; Gauna ML; Claros R; López EL; Savy VL; Luna CM
    Int J Infect Dis; 2014 Feb; 19():20-5. PubMed ID: 24211378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.
    Lu CY; Shao PL; Chang LY; Huang YC; Chiu CH; Hsieh YC; Lin TY; Huang LM
    Vaccine; 2010 Aug; 28(36):5864-70. PubMed ID: 20600484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Sero-epidemiological survey on general community population to understand the infection status after the first wave of pandemic 2009 H1N1 influenza in Guangdong province].
    Li LH; Zhang X; Zhong HJ; Lin WQ; Zhang ZM; Li H; He JF; Lin JY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1329-31. PubMed ID: 21223657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Population exposure to a novel influenza A virus over three waves of infection.
    Adamson WE; McGregor EC; Kavanagh K; McMenamin J; McDonagh S; Molyneaux PJ; Templeton KE; Carman WF
    J Clin Virol; 2011 Dec; 52(4):300-3. PubMed ID: 21924675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Etiological characteristics of influenza A (H1N1) 2009 virus in Beijing].
    Huang F; Guo J; Cui SJ; Lü YN; Gao ZY; Li WH; Yan HQ; Qu M; Shi WX; Lu GL; Zhang X; Zhang DT; Tian LL; Qian HK; Yang P; Pang XH; Wang QY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 May; 31(5):494-6. PubMed ID: 21163022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis of influenza type A(H1N1) antibody levels in different population in Gansu province].
    Yu DS; Li HY; Gao XM
    Zhongguo Yi Miao He Mian Yi; 2010 Jun; 16(3):219-21, 260. PubMed ID: 20726261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus.
    Scalera NM; Mossad SB
    Postgrad Med; 2009 Sep; 121(5):43-7. PubMed ID: 19820273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.
    Han F; Lin L; Warby SC; Faraco J; Li J; Dong SX; An P; Zhao L; Wang LH; Li QY; Yan H; Gao ZC; Yuan Y; Strohl KP; Mignot E
    Ann Neurol; 2011 Sep; 70(3):410-7. PubMed ID: 21866560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pandemic 2009 influenza A (H1N1) virus among Japanese healthcare workers: seroprevalence and risk factors.
    Nukui Y; Hatakeyama S; Kitazawa T; Mahira T; Shintani Y; Moriya K
    Infect Control Hosp Epidemiol; 2012 Jan; 33(1):58-62. PubMed ID: 22173523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.
    Wu J; Xu F; Lu L; Lu M; Miao L; Gao T; Ji W; Suo L; Liu D; Ma R; Yu R; Zhangzhu J; Liu W; Zeng Y; Li X; Zhang X; Pang X; Deng Y
    N Engl J Med; 2010 Dec; 363(25):2416-23. PubMed ID: 21158658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.